載入...
Drug interaction between tacrolimus and nilotinib in a patient with chronic myeloid leukemia after renal transplant
Nilotinib, a BCR‐ABL tyrosine kinase inhibitor, is a known inhibitor of CYP3A4 and could increase the concentration of drugs metabolized by CYP3A4. An immunosuppressive drug for nilotinib‐treated patients following transplant should be administered with careful pharmacokinetic monitoring because of...
Na minha lista:
| 發表在: | Clin Case Rep |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412900/ https://ncbi.nlm.nih.gov/pubmed/28469859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.900 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|